Rhenman & Partners Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Rhenman & Partners Asset Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-64,000	Closed	-$20.8M	–	97
2024 Q1	$20.8M	Sell	64,000 -76,000	-54%	-$18.7M	1.98%	19
2023 Q4	$26.7M	Buy	140,000 +59,000	+73%	+$11.2M	2.67%	9
2023 Q3	$16.1M	Buy	81,000 +25,000	+45%	+$5.91M	1.74%	25
2023 Q2	$16M	Sell	56,000 -11,000	-16%	-$3.05M	1.68%	27
2023 Q1	$14.3M	Buy	67,000 +20,000	+43%	+$3.9M	1.58%	25
2022 Q4	$9.66M	Buy	47,000 +27,000	+135%	+$6.83M	1.01%	38
2022 Q3	$5.86M	Sell	20,000 -50,978	-72%	-$13M	0.61%	53
2022 Q2	$13.6M	Buy	70,978 +16,178	+30%	+$2.86M	1.54%	24
2022 Q1	$11.4M	Buy	54,800 +20,800	+61%	+$3.43M	1.12%	37
2021 Q4	$6.11M	Hold	34,000	–	–	0.41%	63
2021 Q3	$7M	Buy	34,000 +10	+0%	+$1.96K	0.49%	61
2021 Q2	$6.45M	Sell	33,990 -16,010	-32%	-$2.62M	0.44%	73
2021 Q1	$6.51M	Sell	50,000 -10,000	-17%	-$1.2M	0.45%	62
2020 Q4	$6.22M	Hold	60,000	–	–	0.51%	60
2020 Q3	$4.55M	Hold	60,000	–	–	0.4%	66
2020 Q2	$2.84M	Buy	+60,000	New	+$2.47M	0.31%	76

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Rhenman & Partners Asset Management's SWAV Position: Q2 2024 in Review

Rhenman & Partners Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 64,000 shares — an estimated $20.8M sold.

Rhenman & Partners Asset Management first reported a position in SWAV in Q2 2020 and held it in 16 quarters. The position peaked at $26.7M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Rhenman & Partners Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Rhenman & Partners Asset Management sold 64,000 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $20.8M.
Rhenman & Partners Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
Rhenman & Partners Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $26.7M in Q4 2023.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.